GLP 1 medications have rapidly shifted from a niche medical treatment to a mainstream cultural and consumer conversation. As usage grows and awareness spreads, these drugs are beginning to reshape how people think about food, health and everyday eating habits.
Join Lumina Intelligence for an insight led webinar exploring how GLP 1 is influencing consumer attitudes and behaviours across the food and beverage landscape. Weight loss may be the headline story, but the implications go far beyond that. Changes in appetite, shopping habits, nutrition priorities and food occasions are already beginning to emerge among users — with awareness of these shifts extending into the wider population.
In this 20 minute presentation followed by a live Q&A, Flora Zwolinski, Insight Lead at Lumina Intelligence, will present the latest proprietary consumer insights to unpack who is using GLP 1 medications, how they are influencing food behaviours, and what this could mean for foodservice, retail and brands in the years ahead.
The session will conclude with a live Q&A featuring Nicholas Robinson, Editor at FoodNavigator, offering an opportunity to explore the findings in more depth and discuss what businesses should be watching as the GLP 1 landscape continues to evolve.
- How consumer awareness and attitudes towards GLP-1 are evolving
- Who the current GLP-1 consumer is and how this demographic may expand over time
- How GLP-1 usage is beginning to influence eating habits, appetite and food choices
- The emerging shifts in shopping behaviour and food occasions linked to GLP-1
- How the wider population is responding to the rise of GLP-1 medications
- What these behavioural changes could mean for foodservice, retail and innovation
